MedTrace Logo

Study of PLGA-Mg Material in Clinical Orthopedics

NCT03060655 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2017-02-23

No results posted yet for this study

Summary

The different proportion samples of PLGA-Mg were made in this study. Then, they would be placed in the femoral condyle of the New Zealand rabbits. The appropriate proportion of PLGA-Mg is obtained after the experiment, which will be used to make the plate or screw to fix the fragments. Then, the clinical role for bone will be assessed.

Conditions

  • Fracture Dislocation

Interventions

BIOLOGICAL

PLGA-Mg material

The PLGA-Mg material was used to accomplish the fixation of fragments. Then, the clinical outcome was assessed.

BIOLOGICAL

titanium alloy

Traditional fixation was titanium alloy. the clinical outcome was assessed.

Sponsors & Collaborators

  • Hebei Medical University Third Hospital

    lead OTHER

Principal Investigators

  • Ruipeng Zhang, M.D · Third Hospital of Hebei Medical University Department of Orthopaedic Surgery

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2018-02-28
Completion
2018-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03060655 on ClinicalTrials.gov